They studied patient-specific iPS-CM carrying a compound Brugada syndrome mutation (p.A226V and p.R1629X), and a mild Brugada syndrome SCN5A mutation (T1620M) in iPS-CM commercially available. Here, SCN5A is linked to Brugada syndrome.